---
figid: PMC8989850__fnins-16-854992-g002
figtitle: Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s
  Disease
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8989850
filename: fnins-16-854992-g002.jpg
figlink: /pmc/articles/PMC8989850/figure/F2/
number: F2
caption: Current AD treatments and targets. Panel (A) commonly accepted AD disease
  progression pathway while highlighting commonly targeted pathways in AD therapeutics,
  (B) visualization of the time point those therapies are tackling in respect to the
  progression of the disease. Portions of the figure was created with BioRender.com.
papertitle: Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s
  Disease.
reftext: Shen Ning, et al. Front Neurosci. 2022;16:854992.
year: '2022'
doi: 10.3389/fnins.2022.854992
journal_title: Frontiers in Neuroscience
journal_nlm_ta: Front Neurosci
publisher_name: Frontiers Media S.A.
keywords: Alzheimer’s disease | neurotechnologies | diagnosis | therapeutic | amyloid
automl_pathway: 0.7754931
figid_alias: PMC8989850__F2
figtype: Figure
redirect_from: /figures/PMC8989850__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8989850__fnins-16-854992-g002.html
  '@type': Dataset
  description: Current AD treatments and targets. Panel (A) commonly accepted AD disease
    progression pathway while highlighting commonly targeted pathways in AD therapeutics,
    (B) visualization of the time point those therapies are tackling in respect to
    the progression of the disease. Portions of the figure was created with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tau
  - Low
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Ass
  - ab
  - Appl
  - SNRPG
  - Gs1
---
